← Esperion Therapeutics, Inc.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash and Cash Equivalents, at Carrying Value | $38.2m | $34.5m | $37.0m | $166.1m | $305.0m | $208.9m | $124.8m | $82.2m | $144.8m | $167.9m | |
| Prepaid Expense and Other Assets, Current | $1.4m | $1.7m | $1.3m | $3.9m | $24.0m | $11.2m | $9.9m | $4.5m | $18.0m | $4.5m | |
| Short-term Investments | — | — | — | — | — | $50.4m | $42.1m | $0 | — | — | |
| Inventory, Net | — | — | — | — | $16.1m | $34.4m | $35.2m | $65.6m | $94.5m | $105.1m | |
| Assets, Current | $213.6m | $203.9m | $142.6m | $211.7m | $345.9m | $329.0m | $246.7m | $201.1m | $338.0m | $462.6m | |
| Property, Plant and Equipment, Net | $674k | $435k | $520k | $1.1m | $1.3m | $664k | $164k | $0 | $254k | $338k | |
| Intangible Assets, Net (Excluding Goodwill) | — | — | — | — | — | $56k | $56k | — | — | — | |
| Operating Lease, Right-of-Use Asset | — | — | — | $1.5m | $6.0m | $1.9m | $1.0m | $4.7m | $5.5m | $2.9m | |
| Additional Financial Items | |||||||||||
| Accounts Receivable, after Allowance for Credit Loss, Current | — | — | — | — | — | $22.9m | $33.7m | $48.5m | $80.1m | $140.2m | |
| Assets | $245.2m | $277.8m | $143.5m | $214.4m | $353.3m | $381.6m | $247.9m | $205.8m | $343.8m | $465.9m | |
| LIABILITIES AND EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Operating Lease, Liability, Current | — | — | — | $454k | $2.6m | $1.4m | $384k | $1.6m | $2.7m | $2.1m | |
| Accounts Payable, Current | $4.6m | $20.4m | $44.9m | $28.9m | $52.0m | $17.6m | $23.0m | $31.7m | $51.6m | $65.1m | |
| Operating Lease, Liability, Noncurrent | — | — | — | $1.1m | $3.5m | $524k | $665k | $3.0m | $2.6m | $653k | |
| Long-term Debt, Current Maturities | $1.7m | $1.0m | — | — | — | — | — | — | — | — | |
| Long-term Debt, Excluding Current Maturities | $1.0m | — | — | — | — | — | — | $0 | $141.0m | $152.2m | |
| Liabilities, Current | $15.6m | $33.1m | $64.3m | $66.1m | $94.1m | $73.4m | $92.3m | $156.2m | $246.2m | $300.8m | |
| Other Liabilities, Noncurrent | — | — | — | — | $1.3m | $0 | — | — | — | $8.7m | |
| Liabilities | $16.6m | $33.1m | $64.3m | $194.5m | $449.4m | $578.5m | $571.7m | $660.8m | $732.5m | $767.9m | |
| Stockholders’ equity: | |||||||||||
| Preferred Stock, Value, Issued | — | — | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Common Stock, Value, Issued | $23k | $26k | $27k | $27k | $26k | $61k | $75k | $118k | $196k | $245k | |
| Additional Paid in Capital | $458.0m | $641.8m | $677.5m | $715.2m | $797.7m | $964.4m | $1.1b | $1.1b | $1.3b | $1.4b | |
| Retained Earnings (Accumulated Deficit) | ($229.2m) | ($396.3m) | ($598.1m) | ($695.3m) | ($838.8m) | ($1.1b) | ($1.3b) | ($1.5b) | ($1.6b) | ($1.6b) | |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | ($172k) | ($845k) | ($319k) | $23k | $0 | ($31k) | ($2k) | $0 | $0 | $0 | |
| Stockholders' Equity Attributable to Parent | $228.6m | $244.7m | $79.1m | $19.9m | ($96.1m) | ($196.9m) | ($323.8m) | ($455.0m) | ($388.7m) | ($302.0m) | |
| Liabilities and Equity | $245.2m | $277.8m | $143.5m | $214.4m | $353.3m | $381.6m | $247.9m | $205.8m | $343.8m | $465.9m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.